Biological and pharmacological roles of m(6)A modifications in cancer drug resistance

Cancer drug resistance represents the main obstacle in cancer treatment. Drug-resistant cancers exhibit complex molecular mechanisms to hit back therapy under pharmacological pressure. As a reversible epigenetic modification, N(6)-methyladenosine (m(6)A) RNA modification was regarded to be the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zaoqu, Zou, Haijiao, Dang, Qin, Xu, Hui, Liu, Long, Zhang, Yuyuan, Lv, Jinxiang, Li, Huanyun, Zhou, Zhaokai, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749187/
https://www.ncbi.nlm.nih.gov/pubmed/36517820
http://dx.doi.org/10.1186/s12943-022-01680-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749187/
https://www.ncbi.nlm.nih.gov/pubmed/36517820
http://dx.doi.org/10.1186/s12943-022-01680-z

Ejemplares similares